Modalis Therapeutics Corporation's market cap is currently ¥7.15B. The company's EPS TTM is ¥-52.59; its P/E ratio is ―; Modalis Therapeutics Corporation is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	¥ 0.00	¥ 40.50M	¥ 1.10M	¥ 342.00M	¥ 644.00M
Gross Profit	¥ -731.00K	¥ -83.17M	¥ 1.10M	¥ 342.00M	¥ 644.00M
Operating Income	¥ -2.37B	¥ -2.06B	¥ -1.24B	¥ -398.35M	¥ 157.00M
EBITDA	¥ -2.37B	¥ -2.58B	¥ -667.55M	¥ -381.96M	¥ 0.00
Net Income	¥ -2.39B	¥ -2.70B	¥ -738.96M	¥ -448.41M	¥ 140.00M
Balance Sheet
Cash & Short-Term Investments	¥ 1.88B	¥ 2.93B	¥ 4.94B	¥ 5.42B	¥ 3.86B
Total Assets	¥ 2.03B	¥ 3.13B	¥ 6.07B	¥ 6.28B	¥ 3.94B
Total Debt	¥ 412.50M	¥ 0.00	¥ 0.00	¥ 0.00	¥ 0.00
Net Debt	¥ -1.47B	¥ -2.93B	¥ -4.94B	¥ -5.42B	¥ -3.86B
Total Liabilities	¥ 645.50M	¥ 188.60M	¥ 519.92M	¥ 70.16M	¥ 15.17M
Stockholders' Equity	¥ 1.38B	¥ 2.94B	¥ 5.55B	¥ 6.21B	¥ 3.84B
Cash Flow
Free Cash Flow	¥ -2.29B	¥ -2.09B	¥ -854.58M	¥ -1.21B	¥ 169.86M
Operating Cash Flow	¥ -2.25B	¥ -1.90B	¥ -747.47M	¥ -376.57M	¥ 224.15M
Investing Cash Flow	¥ -39.70M	¥ -185.72M	¥ 171.56M	¥ -830.31M	¥ -61.77M
Financing Cash Flow	¥ 1.22B	¥ 63.68M	¥ 72.63M	¥ 2.78B	¥ 2.49B

Currency in JPY

Modalis Therapeutics Corporation Earnings and Revenue History

Income Statement >

Modalis Therapeutics Corporation Debt to Assets

Balance Sheet >

Modalis Therapeutics Corporation Cash Flow

Cash Flow >

Modalis Therapeutics Corporation Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing